Eli Lilly (TSAT)-Enrollment closed
A randomized, double blind, placebo controlled parallel study with an open label extension to assess the impact of testosterone solution on total testosterone, sex drive and energy in hypogonadal men.
Inclusion Criteria:
- Age > 18 years
- Total testosterone level <300ng/dl obtained at each of the 2 screening visits
- Currently have at least 1 symptom of testosterone deficiency, which must include decreased energy or decreased sexual drive
- PSA < 4 ng/ml at visit 2
- Individuals who have not received oral or topical testosterone therapy within 14 days prior to visit 1.